Compared to SQUID-based MEG, OPMs are more sensitive to epileptiform activity from deeper brain stuctures, and in children. OPMs can also succesfully record seizure activity.
ID
Bron
Verkorte titel
Aandoening
Epilepsy
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Primary outcome is a demonstration of the effectiveness of OPMs as a powerful diagnostic tool in epilepsy. The parameter we study is epileptiform activity (spikes, spike-waves). We will compare the even-rate (number of spikes/minute) and the strength (in terms of signal-to-noise ratio) between the different techniques (OPM-based MEG versus SQUID-based MEG, and scalp EEG or dEEG). OPM-based MEG will be considered more effective if the event-rate or strength is higher than for the SQUID-based MEG.
Achtergrond van het onderzoek
For patients with focal refractory epilepsy, seizure freedom can be achieved through epilepsy surgery by removal of the epileptogenic zone (EZ). This requires the delineation of the EZ during the pre-surgical workup using non-invasive techniques such as Magneto/Electro-encephalography (MEG/EEG), or invasive recordings using intracranial electrodes (dEEG). The success of the pre-surgical workup, and thereby surgery, should be improved since seizure freedom is achieved in only two-thirds of the patients.
Newly developed MEG sensors, so-called Optically Pumped Magnetometers (OPMs), provide an unprecedented opportunity for epilepsy. These sensors are smaller, lighter, and cheaper, yet have a sensitivity that is comparable to that of cryogen-based Superconducting Quantum Interference Devices (SQUIDs). Importantly, they can be placed directly on the scalp, thereby improving the sensitivity to, and localisation accuracy of, epileptiform activity. Moreover, with a wearable OPM-based array, one could record during seizures. Together, this will not only improve diagnosis, but also the pre-surgical workup, thereby improving the chances of successful surgery and seizure freedom.
In this study we aim to demonstrate that novel MEG sensors can be used successfully in clinical practice, and to demonstrate their effectiveness as a powerful diagnostic tool in epilepsy.
Doel van het onderzoek
Compared to SQUID-based MEG, OPMs are more sensitive to epileptiform activity from deeper brain stuctures, and in children. OPMs can also succesfully record seizure activity.
Onderzoeksopzet
OPM-based and SQUID-based MEG data will be collected during a single visit to Amsterdam UMC - location VUmc
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Patients have refractory epilepsy (not responding to treatment with anti-epileptic
drugs) and are candidates for epilepsy surgery at VUmc (adults) or UMCU (children).
- We include adults (VUmc) or children of six years of age or older (UMCU).
Adults:
- Patients have already undergone a clinical SQUID-based MEG and dEEG at VUmc
- 3 patients: confirmed focal source on dEEG of mesial temporal origin
- 1 patient: frequent seizures (~daily)
Children:
- Six years of age or older
- Patients have already undergone a clinical SQUID-based MEG with simultaneous
scalp-EEG at VUmc
- Confirmed focal source of epileptiform activity in clinical MEG or EEG
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Already undergone surgery for their current epilepsy
- The patients have already undergone a clinical SQUID-based MEG. Those patients
who had claustrophobic or anxiety experiences from being enclosed in the
magnetically shielded room will be excluded
- Patients with many artefacts, related to either movement (restlessness, i.e. not
seizure-related) or metal implants (not MEG compatible), on their clinical SQUIDbased
MEG
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL8920 |
Ander register | Netherlands Epilepsy Foundation (NEF) : EC19-05 |